CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Collate›
Analysis
Collate

Collate

Collate builds an AI-native operating platform for elective-procedure and aesthetic clinics.

Istanbul, TR🇹🇷
Founded
2025
Loading
Overview
Analysis
Compare
Employees
News
Library

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  4. 04Pricing Strategy
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  4. 04Pricing Strategy

Product Overview

Collate builds an AI-native operating platform for elective-procedure clinics, spanning medspa, aesthetic surgery, and dental practices. The platform covers two connected jobs: bringing patient enquiries in from every channel a clinic uses, and giving clinic staff a single pipeline to work those enquiries toward a booked procedure.

The offering is delivered as three product lines. Collate ClinicOS unifies inbound communication and patient-pipeline tracking, Collate Voice answers inbound clinic calls, and Collate Customer Acquisition manages search and AI-search visibility.

Source: collatelabs.com

Market Outlook

Elective-procedure clinics compete for patients as commercial businesses, but the software built for urgent healthcare does not match how they work. Their enquiries are rarely urgent or high-risk, which means the tools that suit hospitals fit their front desk poorly.

Clinics in this segment spend heavily on advertising, social media, and search visibility without clear visibility into which spend produces patients. Software that connects acquisition to a tracked patient pipeline addresses that gap, and demand for it is growing as more patient research shifts toward AI assistants and map results.

Source: collatelabs.com

Competitive Advantages

Collate's advantage is the breadth of the clinic workflow it covers in one system. Rather than selling a point tool, it combines inbound communication capture, an AI voice agent, patient-pipeline tracking, and search visibility, which lets a clinic keep every enquiry in one place from first message through to a booked procedure.

That combination matters most for elective-procedure clinics, whose enquiries arrive across messaging apps, social media, phone, and web forms rather than a single channel. Collate's knowledge base is built from each clinic's own procedures and policies, so its AI answers reflect how that clinic actually operates.

Source: collatelabs.com

Pricing Strategy

Collate sells to clinics as subscription software. Its published comparison material positions the product against the recurring cost of search agencies, and against manual in-house administration of patient enquiries.

The company markets a free audit as an entry point for prospective clinic customers, and states a thirty-day money-back guarantee with no required commitment. Detailed plan pricing is not published on its public site.

Source: collatelabs.com